A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

PHASE2RecruitingINTERVENTIONAL
Enrollment

740

Participants

Timeline

Start Date

February 26, 2024

Primary Completion Date

September 1, 2027

Study Completion Date

October 10, 2028

Conditions
Advanced Solid TumorMelanomaHead and Neck CancerGastric CancerOvarian CarcinomaCervical CancerEndometrial CancerBladder CancerEsophageal CancerPancreatic CarcinomaProstate CancerNon-small Cell Lung Cancer (NSCLC)Lung CancerBreast Cancer
Interventions
DRUG

HER3-DXd

Intravenous infusion 5.6 mg/kg administered Q3W on Day 1 of each 21-day cycle

Trial Locations (80)

333

RECRUITING

Chang Gung Memorial Hospital, Taoyuan District

704

RECRUITING

National Cheng Kung University Hospital, Tainan City

833

RECRUITING

Kaohsiung Chang Gung Memorial Hospital, Kaohsiung City

1478

RECRUITING

Akershus universitetssykehus, Lørenskog

RECRUITING

Haukeland universitetssjukehus, Lørenskog

2050

RECRUITING

Chris O'Brien Lifehouse, Camperdown

2650

RECRUITING

UZA, Edegem

3000

RECRUITING

UZ Leuven, Leuven

3168

RECRUITING

Monash Medical Centre Clayton, Clayton

4032

RECRUITING

Icon Cancer Centre Chermside, Chermside

4812

RECRUITING

Icon Cancer Centre Townsville, Hyde Park

6000

RECRUITING

Bacs-Kiskun Varmegyei Oktatokorhaz, Kecskemét

7000

RECRUITING

Icon Cancer Centre Hobart, Hobart

9000

RECRUITING

Universitair Ziekenhuis Gent, Ghent

10065

RECRUITING

Memorial Sloan Kettering Hospital, New York

11217

RECRUITING

Taipei Veterans General Hospital, Taipei

13005

RECRUITING

Hăpital de La Timone, Marseille

13496

RECRUITING

Cha Bundang Medical Center, Cha University, Seongnam

13620

RECRUITING

Seoul National University Bundang Hospital, Seongnam

14203

RECRUITING

Roswell Park Cancer Institute IDS, Buffalo

16132

RECRUITING

IRCCS Ospedale Policlinico San Martino, Genova

21079

RECRUITING

Centre Georges Franăois Leclerc, Dijon

21205

RECRUITING

Johns Hopkins University, Baltimore

28009

RECRUITING

Hospital General Universitario Gregorio Marañon, Madrid

28034

RECRUITING

Hospital Universitario Ramon Y Cajal, Madrid

28041

RECRUITING

Hospital Universitario 12 de Octubre, Madrid

29010

RECRUITING

HOSPITAL REGIONAL UNIVERSITARIO de MALAGA AVDA., Málaga

31100

RECRUITING

Institut Claudius Regaud, Toulouse

33000

RECRUITING

Chu Bordeaux, Bordeaux

34747

RECRUITING

AdventHealth Medical Group Oncology Research at Celebration, Kissimmee

37134

RECRUITING

Centro Ricerche Cliniche di Verona s.r.l., Verona

37203

RECRUITING

SCRI Oncology Partners, Nashville

41009

RECRUITING

Hospital Universitario Virgen Macarena, Seville

44093

RECRUITING

Chu Nantes - Hătel Dieu, Nantes

46010

RECRUITING

Hospital Clinico Universitario de Valencia, Valencia

55101

RECRUITING

Health Partners Cancer Center at Regions Hospital, Saint Paul

55426

RECRUITING

Health Partners Frauenshuh Cancer Center, Saint Louis Park

59000

RECRUITING

Hopital Claude Huriez - Chu Lille, Lille

60612

RECRUITING

University of Illinois Cancer Center, Chicago

63110

RECRUITING

Washington University, School of Medicine, St Louis

69008

RECRUITING

Centre Léon Bérard, Lyon

77030

RECRUITING

The University of Texas MD Anderson Cancer Center, Houston

80131

RECRUITING

AOU Federico II - Oncologia Clinica, Napoli

91010

RECRUITING

City of Hope, Duarte

94805

RECRUITING

Institut Gustave Roussy, Villejuif

98109

RECRUITING

Fred Hutchinson Cancer Center, Seattle

100225

RECRUITING

National Taiwan University Hospital, Taipei

06510

RECRUITING

Yale Cancer Center, New Haven

Unknown

RECRUITING

Cliniques Universitaires Saint-Luc, Brussels

RECRUITING

Universitair Ziekenhuis Brussel, Jette

T6G 1Z2

RECRUITING

Cross Cancer Institute, Edmonton

M4N 3M5

RECRUITING

Sunnybrook Research Institute, Toronto

M5G2M9

RECRUITING

Princess Margaret Cancer Centre, Toronto

V5Z4E6

RECRUITING

BC Cancer - Vancouver, Vancouver

350-1298

RECRUITING

Saitama Medical University International Medical Center, Hidaka

277-8577

RECRUITING

National Cancer Center Hospital East, Kashiwa-shi

791-0245

RECRUITING

NHO Shikoku Cancer Center, Matsuyama

411-8777

RECRUITING

Shizuoka Cancer Center, Nagaizumi-cho

464-8681

RECRUITING

Aichi Cancer Center Hospital, Nagoya

589-8511

RECRUITING

Kindai University Hospital, Osakasayama-shi

104-0045

RECRUITING

National Cancer Center Hospital, Tokyo

135-8550

RECRUITING

Cancer Institute Hospital of JFCR, Tokyo

232-0024

RECRUITING

Yokohama City University Medical Center, Yokohama

1081 HV

RECRUITING

Amsterdam UMC locatie Vumc, Amsterdam

9713 GZ

RECRUITING

Universitair Medisch Centrum Groningen, Groningen

2333 ZG

RECRUITING

Leids Universitair Medisch Centrum, Leiden

6229 HX

RECRUITING

Maastricht University Medical Center, Maastricht

6525 GA

RECRUITING

Radboud University Medical Center, Nijmegen

0379

RECRUITING

Oslo Universitetssykehus HF, Radiumhospitalet, Oslo

03080

RECRUITING

Seoul National University Hospital, Seoul

03722

RECRUITING

Severance Hospital, Yonsei University Health System, Seoul

05505

RECRUITING

Asan Medical Center, Seoul

06351

RECRUITING

Samsung Medical Center, Seoul

08035

RECRUITING

Hospital Universitari Vall D'Hebron, Barcelona

08036

RECRUITING

Hospital Clinic de Barcelona, Barcelona

08041

RECRUITING

Hospital de La Santa Creu I Sant Pau, Barcelona

CV2 2DX

RECRUITING

University Hospital Coventry, Coventry

EC1A 7BE

RECRUITING

Barts Hospital, London

NW3 2QG

RECRUITING

Royal Free Hospital, London

NG5 1PB

RECRUITING

Nottingham City Hospital Campus, Nottingham

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Merck Sharp & Dohme LLC

INDUSTRY

lead

Daiichi Sankyo

INDUSTRY

NCT06172478 - A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors | Biotech Hunter | Biotech Hunter